U.S. survey links kratom use with cannabis and heroin use, with sex differences

Kratom Use Among U.S. Adults: Clinical Characteristics and Sex Differences in Co-Occurring Drug Use.

Substance use & misuse • • Moderately Relevant
🤖

AI Summary

This study used 2022–2023 U.S. National Survey on Drug Use and Health data to estimate lifetime kratom use among adults and examine its demographic, mental-health, behavioral, and substance-use correlates. The estimated lifetime prevalence was 1.95%; among adults reporting lifetime use, 34.84% also reported past-year use and 18.39% past-month use. These are survey associations, not evidence that kratom caused the characteristics observed.

Lifetime kratom use was associated with lifetime major depressive episodes, use of pain-relieving medications, and past-year serious psychological distress. Lifetime cannabis and heroin use were associated with higher odds of kratom use in both sexes, but the cannabis association was stronger in males and the heroin association weaker in males than in females. Because this is an observational analysis of self-reported survey data, it cannot establish causation or show whether screening or intervention would help; this is an abstract-based summary, not a review of the full text.

💡 Key Findings

1
In the 2022–2023 U.S. adult survey, estimated lifetime kratom use prevalence was 1.95%; the abstract also reports past-year and past-month use among respondents with lifetime use.
High
90%
2
Lifetime kratom use was associated with major depressive episodes, pain-relieving medication use, and serious psychological distress; these associations do not establish cause and effect.
High
80%
3
Lifetime cannabis and heroin use were associated with elevated odds of kratom use in both sexes. The cannabis association was over three times stronger in males, while the heroin association was approximately half as strong in males compared with females.
High
80%

📄 Original Abstract

BACKGROUND: The expansion of kratom's availability, popularity, and product diversity in the United States has drawn scientific and national attention. Characterizing the sociodemographic and behavioral correlates of kratom use may help public health efforts. METHOD: We examined data from the National Survey of Drug Use and Health (2022-2023), to investigate lifetime prevalence and sociodemographic, mental health, and behavioral correlates of self-reported use of kratom as well as the interaction of cannabis and heroin with sex, given co-used patterns with kratom and report sex differences. RESULTS: A pooled prevalence estimate of lifetime kratom use among U.S. adults (18+) was 1.95%, of whom 34.84% reported past-year use and 18.39% reported past-month use. Among those with past-year use, 52.79% reported past-month use. Lifetime use was most common among White, unmarried, younger, working males and those with lower incomes, living in poverty, and participating in government assistance programs. In multivariable analysis, lifetime kratom use was associated with lifetime major depressive episodes, use of pain-relieving medications, and past-year serious psychological distress. Lifetime cannabis and heroin use were associated with elevated odds of kratom use in both sexes. However, kratom's relationship with cannabis use was over three times stronger in males, while its relationship with heroin use was approximately half as strong in males compared to females. CONCLUSION: Kratom use was correlated with specific demographic, behavioral, and sex- and substance-specific characteristics, suggesting the need for more study to examine whether certain populations may benefit from targeted screening and intervention.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.